Filtered By:
Specialty: Pharmaceuticals
Condition: Heart Attack
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 165 results found since Jan 2013.
Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial Fibrillation
RARITAN, NJ, May 25, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that all three prospective indications for milvexian, an investigational oral factor XIa (FXIa) inhibitor (being developed in collaboration with Bristol Myers Squibb), have now been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). The designations cover all three indication-seeking studies within the Phase 3 Librexia development program (Librexia STROKE, Librexia ACS and Librexia AF), which are all dosing patients. The Librexia program is unrivaled as the most comprehensive FXIa clinical...
Source: Johnson and Johnson - May 25, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
ASA: Increased Odds of Stroke, MI With E-Cigarette Use
WEDNESDAY, Jan. 30, 2019 -- Electronic cigarette use is associated with increased odds of stroke, myocardial infarction, and angina or coronary heart disease, according to a study presented at the American Stroke Association International Stroke...
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news
Amgen and Jay Leno Partner to Sound the Alarm on High Cholesterol and its Link to Heart Attack and Stroke in Patients Most at Risk
If You've had a Heart Attack or Stroke, Your Risk of Having Another Cardiovascular Event is Nearly One in Three(1)
Cholesterol 911 Urges These High-Risk Patients to See the Emergency in High Cholesterol and Talk to Their Doctor About Ways to Reduce the Risk of Another Heart Attack and Stroke
THOUSAND OAKS, Calif., March 12, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today launched Cholesterol 911, a national initiative urging high-risk cardiovascular disease patients to reduce their risk of another heart attack or stroke by addressing their continued high LDL-C, or "bad" cholesterol. Comedian and television host Jay ...
Source: Amgen News Release - March 12, 2019 Category: Pharmaceuticals Tags: Uncategorized Source Type: news
Aspirin green light for brain bleed stroke patients, study finds
People who suffer a stroke caused by bleeding in the brain - known as brain haemorrhage - can take common medicines without raising their risk of another stroke, a major clinical trial has found. Researchers say the findings are reassuring for the thousands of people who take the medicines to reduce their risk of heart attack and another common type of stroke caused by blood clots in the brain.
Source: World Pharma News - May 23, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Amgen Receives European Commission Approval For Repatha ® (Evolocumab) To Prevent Heart Attack And Stroke In Adults With Established Cardiovascular Disease
New Indication Supports Amgen's Commitment to Reduce the Risk of Recurrent Cardiovascular Events Faced by Heart Attack and Stroke Survivors
Amgen Announces Efforts to Improve Repatha's Affordability Across Europe for Payers who Significantly Expand Patient Access
THOUSAND OAKS, Calif., May 16, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has approved a new indication in the Repatha® (evolocumab) label for adults with established atherosclerotic cardiovascular disease (myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by lowerin...
Source: Amgen News Release - May 16, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news
Antioxidant reduces risk for second heart attack, stroke
Doctors have long known that in the months after a heart attack or stroke, patients are more likely to have another attack or stroke. Now, a paper in the Journal of the American College of Cardiology explains what happens inside blood vessels to increase risk - and suggests a new way to treat it.
Source: World Pharma News - September 4, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Green Tea Consumption Improves Prognosis for Stroke, MI Survivors
THURSDAY, Feb. 4, 2021 -- For stroke and myocardial infarction (MI) survivors, green tea consumption is associated with improved prognosis, according to a study published online Feb. 4 in Stroke.
Masayuki Teramoto, M.D., from the Osaka University...
Source: Drugs.com - Pharma News - February 4, 2021 Category: Pharmaceuticals Source Type: news
Women With Migraine Have Higher Risk for Heart Attack, Hemorrhagic Stroke
TUESDAY, June 13, 2023 -- The risk for ischemic stroke in individuals with migraine is similar for men and women, while the risk for myocardial infarction (MI) and hemorrhagic stroke is only higher in women with migraine, according to a study...
Source: Drugs.com - Pharma News - June 13, 2023 Category: Pharmaceuticals Source Type: news
Snoring: A New Tip-Off To Stroke and Heart Disease
Snoring isn't just annoying, it's a warning sign of artery damage and potential stroke and heart attack, new research says.
Source: Forbes.com Healthcare News - January 29, 2013 Category: Pharmaceuticals Authors: Melanie Haiken Source Type: news
US Drug Watchdog Now Urges Any Woman Who had A Out Of The Blue Stroke...
The US Drug Watchdog says, “We now fear a young healthy woman would probably never consider the possibility of birth control pills being responsible for a out of the blue heart attack, stroke,...(PRWeb February 22, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10431559.htm
Source: PRWeb: Medical Pharmaceuticals - February 23, 2013 Category: Pharmaceuticals Source Type: news
New Lawsuit on Granuflo Stroke: Now, AttorneyOne Can Provide Advice
According to court documents, on January25th, 2013 a man filed a lawsuit in Louisiana Eastern District Court alleging he suffered heart attack and stroke following hemodialysis treatment with Granuflo...(PRWeb April 15, 2013)Read the full story at http://www.prweb.com/releases/2013/4/prweb10631314.htm
Source: PRWeb: Medical Pharmaceuticals - April 18, 2013 Category: Pharmaceuticals Source Type: news
Safety Announcement Issued by FDA to Investigate Risk of Stroke, Heart...
Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, reports that the FDA has issued a Safety Announcement that it will investigate the risk of stroke, heart attack, and death for men...(PRWeb March 16, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11673176.htm
Source: PRWeb: Medical Pharmaceuticals - March 16, 2014 Category: Pharmaceuticals Source Type: news
Merck's Zontivity gets FDA approval to reduce heart attacks and stroke risk in patients
Merck has received approval from the US Food and Drug Administration (FDA) for Zontivity (vorapaxar) for people at high-risk of heart attack or stroke.
Source: Pharmaceutical Technology - May 13, 2014 Category: Pharmaceuticals Source Type: news
Women: Don't Use Aspirin For Routine Prevention Of Heart Attacks, Stroke, And Cancer
Although once widely recommended, aspirin for the prevention of a first heart attack or stroke (primary prevention) has lost favor in recent years, as the large number of bleeding complications appeared to offset the reduction in cardiovascular events. But at the same time evidence has emerged demonstrating the long-term effect of aspirin in preventing colorectal cancer, leading some to think that the risk-to-benefit equation for aspirin should be reconsidered.
Source: Forbes.com Healthcare News - December 5, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
FDA Strengthens NSAIDs Heart Attack, Stroke Warning
Based on the FDA's comprehensive review of new safety information, the agency is strengthening an existing label warning that NSAIDs increase the chance of a heart attack or stroke.
Source: PharmaManufacturing.com - July 14, 2015 Category: Pharmaceuticals Source Type: news
